SCHEMBL19356997

SCHEMBL19356997

CCOC(=O)c1cc(OC)n(-c2ccccc2Cl)n1

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.61
KMT2A Q03164 5/20 0.53
GAA P10253 1/20 0.53
MAPT P10636 5/20 0.53
TP53 P04637 3/20 0.53
TDP1 Q9NUW8 2/20 0.53
POLB P06746 1/20 0.53
LMNA P02545 1/20 0.52
PDE4A P27815 1/20 0.48
PDE4C Q08493 1/20 0.48
PDE4D Q08499 1/20 0.48
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 2/20 0.47
RXFP1 Q9HBX9 1/20 0.47
HPGD P15428 1/20 0.47
THRB P10828 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2843332 0.85 PDE4B (0.60) PDE4BKMT2AGAAMAPTTP53
SCHEMBL14357204 0.84 PDE4B (0.62) PDE4BKMT2AGAAMAPTTP53
SCHEMBL2320255 0.83 MARS1 (0.49) PDE4BKMT2AMAPTMEN1ALDH1A1
SCHEMBL2838912 0.82 PDE4B (0.53) PDE4BKMT2AGAAMAPTTP53
SCHEMBL15456724 0.82 CA9 (0.60) PDE4BKMT2AGAAMAPTTP53
SCHEMBL4693715 0.80 CHRNA7 (0.61) PDE4BKMT2AMEN1ALDH1A1
SCHEMBL2325246 0.78 PDE4B (0.51) PDE4BKMT2AGAAMAPTMEN1
SCHEMBL2839720 0.77 PDE4B (0.47) PDE4BKMT2AGAAMAPTTP53
SCHEMBL2258851 0.77 TP53 (0.50) PDE4BKMT2AGAAMAPTTP53
SCHEMBL3691833 0.77 PDE4B (0.51) PDE4BKMT2AGAAMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200288710-A1 SUBSTITUTED SULPHONAMIDES FOR CONTROLLING ANIMAL PESTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-09-17 US disclosed
US-20200288710-A1 SUBSTITUTED SULPHONAMIDES FOR CONTROLLING ANIMAL PESTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2020-09-17 US disclosed
EP-3429355-B1 SUBSTITUTED SULFONYLAMIDE FOR COMBATING ANIMAL PESTS BAYER CROPSCIENCE AG (DE) 2020-02-05 EP disclosed
EP-3429355-B1 SUBSTITUTED SULFONYLAMIDE FOR COMBATING ANIMAL PESTS BAYER CROPSCIENCE AG (DE) 2020-02-05 EP disclosed
EP-3429355-A1 SUBSTITUTED SULFONYL AMIDES FOR CONTROLLING ANIMAL PESTS Bayer CropScience AG (DE) 2019-01-23 EP disclosed
WO-2017157735-A1 SUBSTITUTED SULFONYL AMIDES FOR CONTROLLING ANIMAL PESTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-09-21 WO disclosed
WO-2017157735-A1 SUBSTITUTED SULFONYL AMIDES FOR CONTROLLING ANIMAL PESTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2017-09-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200288710-A1 SUBSTITUTED SULPHONAMIDES FOR CONTROLLING ANIMAL PESTS DDT, MPST, STOM PDE4B 2168/4885KMT2A 392/4885GAA 697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.